Ultragenyx Pharmaceutical
RARE
#4671
Rank
HK$15.31 B
Marketcap
HK$158.51
Share price
1.89%
Change (1 day)
-48.19%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$15.31 Billion

As of March 2026 Ultragenyx Pharmaceutical has a market cap of HK$15.31 Billion. This makes Ultragenyx Pharmaceutical the world's 4671th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$15.31 B-40.32%
2025HK$25.66 B-17.55%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On Mar 22nd, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$15.03 Billion
by Nasdaq info icon info icon
HK$15.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
HK$5.17 B-66.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$5.26 B-65.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.40 B 131.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$82.57 B 439.11%๐Ÿ‡บ๐Ÿ‡ธ USA